E
Elizabeth Swann
Researcher at Loughborough University
Publications - 23
Citations - 576
Elizabeth Swann is an academic researcher from Loughborough University. The author has contributed to research in topics: Indolequinones & Indolequinone. The author has an hindex of 14, co-authored 23 publications receiving 568 citations. Previous affiliations of Elizabeth Swann include Anschutz Medical Campus & University of Exeter.
Papers
More filters
Journal ArticleDOI
Synthesis of functionalised fluorescent dyes and their coupling to amines and amino acids
Mark Samuel Jonathan Briggs,Ian Edward Bruce,James N. Miller,Christopher J. Moody,Adrian C. Simmonds,Elizabeth Swann +5 more
TL;DR: In this paper, a series of functionalised benzophenoxazinones, analogues of Nile Red, is prepared and their fluorescence properties evaluated. The ring system is prepared by reaction of============5-diethylamino-2-nitrosophenol with 1,6-dihydroxynaphthalene============Initiation of 2-hydroxy group with======6-bromohexanoic acid derivatives.
Journal ArticleDOI
Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
H.D. Beall,Shannon L. Winski,Elizabeth Swann,Anna R. Hudnott,Ann S. Cotterill,Noeleen O'Sullivan,Stephen J. Green,Richard Bien,David Siegel,David Ross,Christopher J. Moody +10 more
TL;DR: A series of indolequinones bearing various functional groups has been synthesized, and the effects of substituents on the metabolism of the quinones by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) revealed that compounds with electron-withdrawing groups at the indole 3-position were among the best substrates, whereas those with amine groups atThe 5- position were poor substrates.
Journal ArticleDOI
Biochemical, Cytotoxic, and Genotoxic Effects of ES936, a Mechanism-Based Inhibitor of NAD(P)H:quinone Oxidoreductase 1, in Cellular Systems
TL;DR: ES936 abrogates the toxicity of streptonigrin, with greater effects seen in cell lines expressing higher levels of NQO1, and does not inhibit other cellular reductases, nor does it alter cellular levels of acid-soluble thiols.
Journal ArticleDOI
N–H Insertion reactions of rhodium carbenoids. Part 3. The development of a modified Bischler indole synthesis and a new protecting-group strategy for indoles
Katherine E. Bashford,Anthony L. Cooper,Peter Kane,Christopher J. Moody,Sendogagounder Muthusamy,Elizabeth Swann +5 more
TL;DR: A modified version of the Bischler indole synthesis has been developed in which the key step is the N-H insertion reaction of rhodium carbene intermediates derived from α-diazo-β-ketoesters with anilines as mentioned in this paper.
Journal ArticleDOI
Cyclopropamitosenes, novel bioreductive anticancer agents. Synthesis, electrochemistry, and biological activity of 7-substituted cyclopropamitosenes and related indolequinones.
Ann S. Cotterill,Christopher J. Moody,Roger J. Mortimer,Claire L. Norton,Noeleen O'Sullivan,Stephens Ma,Nelson Ramos Stradiotto,Elizabeth Swann,Ian J. Stratford +8 more
TL;DR: The synthesis of the indolequinones 8 and 9 starting from methyl 4-(benzyloxy)-5-methoxy-indole-2-carboxylate (10) is described, with many of the compounds in each series showing greater toxicity toward hypoxic cells.